MGC Pharmaceuticals (ASX:MXC) has announced it has received approval to conduct a Phase II clinical trial of a cannabis-based medicine targeting … Read More
The post Green Light For MGC Pharmaceuticals’ Dementia Trial appeared first on Dagga Magazine.